Prevalence of the metabolic syndrome in the island of Gran Canaria: Comparison of three major diagnostic proposals

Diabetic Medicine

Volumn 22, Issue 12, 2005, Pages 1751-1756

  Boronat, Mauro ^a   Chirino, R ^b   Varillas, V F ^c   Saavedra, P ^b   Marrero, D ^a   Fabregas, M ^a   Novoa F J ^a  

^a HOSPITAL UNIVERSITARIO INSULAR DE GRAN CANARIA   (Spain)

^b UNIVERSITY OF LAS PALMAS DE GRAN CANARIA   (Spain)

^c Hospital General de Fuerteventura   (Spain)

Author keywords

Epidemiology; Insulin resistance; Metabolic syndrome; Prevalence

Indexed keywords

GLUCOSE;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; FEMALE; HEALTH SURVEY; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; METABOLIC SYNDROME X; ORAL GLUCOSE TOLERANCE TEST; PHYSICAL EXAMINATION; POPULATION RESEARCH; PRACTICE GUIDELINE; PREVALENCE; SAMPLE SIZE; STRUCTURED QUESTIONNAIRE; WORLD HEALTH ORGANIZATION;

ADULT; AGED; ATLANTIC ISLANDS; BLOOD GLUCOSE; CROSS-SECTIONAL STUDIES; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; REFERENCE VALUES; SPAIN;

EID: 30044433755     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2005.01745.x     Document Type: Article

References (24)

1. Reaven GM. Banting Lecture 1988: role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607.
2. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO Consultation, Part 1: Diagnosis and classification of Diabetes Mellitus. Geneva: World Health Organization 1999, 1-59.
3. Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med 1999; 16: 442-443.
4. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Executive summary of the third report. J Am Med Assoc 2001; 285: 2486-2497.
5. de Pablos-Velasco PL, Martínez-Martín FJ, Rodríguez-Pérez F, Anía BJ, Losada A, Betancor P. Prevalence and determinants of diabetes mellitus and glucose intolerance in a Canarian Caucasian population-comparison of the 1997 ADA and the 1985 WHO criteria. The Guia Study. Diabet Med 2001; 18: 235-241.
6. Boronat M, Varillas VF, Saavedra P, Suárez V, Bosch E, Carrillo A, Nóvoa FJ. Diabetes mellitus and impaired glucose regulation in the Canary Islands (Spain): prevalence and associated factors in the adult population of Telde, Gran Canaria. Diabet Med 2005: doi: 10.111/j1464-5491.2005. 01739.x.
7. Aranceta J, Pérez Rodrigo C, Serra Majem L, Ribas Barba L, Quiles Izquierdo J, Vioque J et al. Prevalence of obesity in Spain: results of the SEEDO 2000 study. Med Clin (Barc) 2003; 120: 608-612.
8. de Pablos-Velasco P, Martínez-Martín FJ, Rodríguez-Pérez F, Urioste LM, García-Robles R. Prevalence, awareness, treatment and control of hypertension in a Canarian population. Relationship with glucose tolerance categories. The Guia Study. J Hypertens 2002; 20: 1965-71.
9. Villar Alvarez F, Banegas Banegas JR, Rodríguez Artalejo F, del Rey Calero J. Cardiovascular mortality in Spain and its autonomous communities (1975-92). Med Clin (Barc) 1998; 110: 321-327.
10. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004; 109: 433-438.
11. Landis RJ, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159-174.
12. Meigs JB, Wilson PW, Nathan DM, D'Agostino RB Sr, Williams K, Haffner SM. Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies. Diabetes 2003; 52: 2160-2167.
13. Ford ES, Giles WH. A comparison of the prevalence of the metabolic syndrome using two proposed definitions. Diabetes Care 2003; 26: 575-581.
14. Hanley AJG, Wagenknecht LE, D'Agostino RB, Zinman B, Haffner SM. Identification of subjects with insulin resistance and β-cell dysfunction using alternative definitions of the metabolic syndrome. Diabetes 2003; 52: 2740-2747.
15. Cameron AJ, Shaw JE, Zimmet PZ. The metabolic syndrome: prevalence in worldwide populations. Endocrinol Metab Clin N Am 2004; 33: 351-375.
16. Ebara F, Glümer C, Jørgensen T, Borch-Johnsen K. Prevalence of the metabolic syndrome in Denmark on the three definitions. The Inter99 Study. Diabetologia 2004; 47: A107.
17. Ilanne-Parikka P, Eriksson JG, Lindström J, Hämälä inen H, Keinänen-Kiukaanniemi S, Lakso M. Prevalence of the metabolic syndrome and its components. Diabetes Care 2004; 27: 2135-2140.
18. Marchesini G, Forlani G, Cerrelli F, Manini R, Natale S, Baraldi L et al. WHO and ATPIII proposals for the definition of the metabolic syndrome in patients with Type 2 diabetes. Diabet Med 2004; 21: 383-387.
19. Ford ES, Giles WH, Mokdad AH. Increasing prevalence of the metabolic syndrome among US adults. Diabetes Care 2004; 27: 2444-2449.
20. The European Group for the Study of Insulin Resistance. Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. Diabetes Metab 2002; 28: 364-376.
21. Hu G, Qiao Q, Tuomiletho J, Balkau B, Borch-Johnsen K, Pyorala K. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in non-diabetic European men and women. Arch Intern Med 2004; 164: 1066-1076.
22. Sentí M, Tomás M, Fitó M, Weinbrenner T, Covas MI, Sala J et al. Antioxidant paraoxonase 1 activity in the metabolic syndrome. J Clin Endocrinol Metab 2003; 88: 5422-5426.
23. Balkau B, Vernay M, Mhamdi L, Novak M, Arondel D, S et al. The incidence and persistence of the NCEP (National Cholesterol Education Program) metabolic syndrome. The French D.E.S.I.R. study. Diabetes Metab 2003, 29, 526-532.
24. Panagiotakos DB, Pitsavos C, Chrysohoou C, Skoumas J, Tousoulis D, Toutouza M et al. Impact of lifestyle habits on the prevalence of the metabolic syndrome among Greek adults from the ATTICA study. Am Heart J 2004; 147: 106-112.